Topic: Flumidine

The discussion turns to the pharmaceutical industry's management of antiviral drugs like Tamiflu and Relenza. Dvorak notes that older, cheaper generics like Flumidine have largely disappeared from the market, while expensive treatments like Tamiflu face rising resistance. They suggest the current flu scare might be a mechanism to deplete aging stockpiles of medication before they become ineffective.